ReviewBrain sciences2020
Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab.
Despoina Florou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
49 papers cite it
this papercites it
ReviewBrain sciences2020
Despoina Florou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.